| Code | CSB-RA875653MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to XKH-001, targeting interleukin-25 (IL-25), also known as IL-17E. IL-25 is a member of the IL-17 cytokine family that plays a critical role in type 2 immune responses by promoting the production of Th2-associated cytokines including IL-4, IL-5, and IL-13. This cytokine is primarily produced by epithelial cells, mast cells, and innate lymphoid cells in response to allergens, parasites, and tissue damage. IL-25 has been implicated in the pathogenesis of allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis, as well as in protective immunity against helminth infections and tissue repair processes.
As a research-grade biosimilar to XKH-001, this antibody provides investigators with a valuable tool for studying IL-25-mediated signaling pathways and its contributions to allergic inflammation and type 2 immunity. It enables researchers to explore therapeutic strategies targeting IL-25 in models of allergic disease and to investigate the broader role of this cytokine in immune regulation and inflammatory disorders.
There are currently no reviews for this product.